AR009651A1 - Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas - Google Patents
Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandasInfo
- Publication number
- AR009651A1 AR009651A1 ARP970105696A ARP970105696A AR009651A1 AR 009651 A1 AR009651 A1 AR 009651A1 AR P970105696 A ARP970105696 A AR P970105696A AR P970105696 A ARP970105696 A AR P970105696A AR 009651 A1 AR009651 A1 AR 009651A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- solubilizing
- indoline
- stabilizing
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde N-sulfonil indolina de formula (I), que comprende uno o varios e constituyentes elegidos entre compuestos anfífilos, agentes tensioactivoshidrofobos no ionicos y compuestos hidrofilos no ionicos dotados a la vez de propiedades anfífilas y tensioactivas, entendiéndose que dicha composicioncomprende al menos o bien una mezcla deun compuesto anfífilo y un agente tensioactivo hidrofilo no ionico, o bien al menos un compuesto hidrofilo noionico dotado a la vez de propiedades tensioactivas y anfífilas. Composicion farmacéutica microemulsionable o emulsionable en medioo acuoso, que comprende:el derivado hidrofobo de N-sulfonil indolina, la composicion solubilizante/ estabilizante, eventualmente un excipiente o vehículo farmacéutico apropiado.Cápsula blanda farmacéutica, que contiene la composicion farmacéutica, en forma líquida, para administracion oral. Cápsula farmacéutica, que contiene lacomposicion farmacéutica, en forma semisolida, para administracion oral. La composicion solubilizante/estabilizante capaz de solubilizar los derivadoshidrofobos deN-sulfonil indolina puede ser utilizada válidamente con miras a introducir esos principios activos en composiciones farmacéuticas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9614957A FR2756736B1 (fr) | 1996-12-05 | 1996-12-05 | Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR009651A1 true AR009651A1 (es) | 2000-04-26 |
Family
ID=9498376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970105696A AR009651A1 (es) | 1996-12-05 | 1997-12-04 | Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0941090A1 (es) |
| JP (1) | JP2000507618A (es) |
| KR (1) | KR20000069308A (es) |
| CN (1) | CN1239887A (es) |
| AR (1) | AR009651A1 (es) |
| AU (1) | AU716575B2 (es) |
| BR (1) | BR9712406A (es) |
| CA (1) | CA2273990A1 (es) |
| CO (1) | CO4910129A1 (es) |
| DZ (1) | DZ2362A1 (es) |
| EE (1) | EE9900206A (es) |
| FR (1) | FR2756736B1 (es) |
| HU (1) | HUP0001386A3 (es) |
| ID (1) | ID23373A (es) |
| IL (1) | IL129936A0 (es) |
| IS (1) | IS5062A (es) |
| MY (1) | MY132819A (es) |
| NO (1) | NO992724L (es) |
| NZ (1) | NZ335750A (es) |
| RU (1) | RU2174394C2 (es) |
| SK (1) | SK75599A3 (es) |
| TR (1) | TR199901702T2 (es) |
| WO (1) | WO1998024430A1 (es) |
| YU (1) | YU23099A (es) |
| ZA (1) | ZA9710919B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2786486B3 (fr) * | 1998-11-16 | 2000-12-08 | Sanofi Sa | Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates |
| DE19913692A1 (de) * | 1999-03-25 | 2000-09-28 | Basf Ag | Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen |
| US6437006B1 (en) | 1999-09-27 | 2002-08-20 | American Cyanamid Company | Pharmaceutical carrier formulation |
| CA2359945C (en) | 1999-11-12 | 2011-04-26 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
| US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
| FR2805992A1 (fr) * | 2000-03-08 | 2001-09-14 | Sanofi Synthelabo | Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline |
| DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
| ITMI20011338A1 (it) | 2001-06-26 | 2002-12-26 | Farmatron Ltd | Composizioni farmaceutiche orali a rilascio immediato del principio attivo |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| UA119324C2 (uk) * | 2013-04-02 | 2019-06-10 | Теміс Медікер Лімітед | Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні |
| KR102139338B1 (ko) * | 2013-06-24 | 2020-07-29 | 주식회사 엘지생활건강 | 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물 |
| KR102139339B1 (ko) * | 2013-06-24 | 2020-07-29 | 주식회사 엘지생활건강 | 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3237814A1 (de) * | 1982-10-12 | 1984-04-12 | Warner-Lambert Co., 07950 Morris Plains, N.J. | Wasserfreie emulsionen und verwendung derselben |
| FR2679903B1 (fr) * | 1991-08-02 | 1993-12-03 | Elf Sanofi | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
-
1996
- 1996-12-05 FR FR9614957A patent/FR2756736B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-03 DZ DZ970212A patent/DZ2362A1/xx active
- 1997-12-04 IL IL12993697A patent/IL129936A0/xx unknown
- 1997-12-04 SK SK755-99A patent/SK75599A3/sk unknown
- 1997-12-04 CO CO97071118A patent/CO4910129A1/es unknown
- 1997-12-04 CN CN97180304A patent/CN1239887A/zh active Pending
- 1997-12-04 BR BR9712406-0A patent/BR9712406A/pt unknown
- 1997-12-04 ID IDW990445D patent/ID23373A/id unknown
- 1997-12-04 JP JP10525294A patent/JP2000507618A/ja active Pending
- 1997-12-04 AU AU53262/98A patent/AU716575B2/en not_active Ceased
- 1997-12-04 NZ NZ335750A patent/NZ335750A/en unknown
- 1997-12-04 ZA ZA9710919A patent/ZA9710919B/xx unknown
- 1997-12-04 KR KR1019997004983A patent/KR20000069308A/ko not_active Ceased
- 1997-12-04 TR TR1999/01702T patent/TR199901702T2/xx unknown
- 1997-12-04 CA CA002273990A patent/CA2273990A1/fr not_active Abandoned
- 1997-12-04 HU HU0001386A patent/HUP0001386A3/hu unknown
- 1997-12-04 AR ARP970105696A patent/AR009651A1/es unknown
- 1997-12-04 EE EEP199900206A patent/EE9900206A/xx unknown
- 1997-12-04 WO PCT/FR1997/002210 patent/WO1998024430A1/fr not_active Ceased
- 1997-12-04 EP EP97950228A patent/EP0941090A1/fr not_active Withdrawn
- 1997-12-04 RU RU99114019/14A patent/RU2174394C2/ru active
- 1997-12-04 MY MYPI97005848A patent/MY132819A/en unknown
-
1999
- 1999-05-26 YU YU23099A patent/YU23099A/sr unknown
- 1999-06-01 IS IS5062A patent/IS5062A/is unknown
- 1999-06-04 NO NO992724A patent/NO992724L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO992724D0 (no) | 1999-06-04 |
| RU2174394C2 (ru) | 2001-10-10 |
| MY132819A (en) | 2007-10-31 |
| SK75599A3 (en) | 2000-08-14 |
| EP0941090A1 (fr) | 1999-09-15 |
| HUP0001386A3 (en) | 2002-03-28 |
| FR2756736A1 (fr) | 1998-06-12 |
| CO4910129A1 (es) | 2000-04-24 |
| EE9900206A (et) | 1999-12-15 |
| BR9712406A (pt) | 1999-08-31 |
| CA2273990A1 (fr) | 1998-06-11 |
| AU716575B2 (en) | 2000-03-02 |
| AU5326298A (en) | 1998-06-29 |
| WO1998024430A1 (fr) | 1998-06-11 |
| FR2756736B1 (fr) | 1999-03-05 |
| JP2000507618A (ja) | 2000-06-20 |
| YU23099A (en) | 1999-11-22 |
| IS5062A (is) | 1999-06-01 |
| DZ2362A1 (fr) | 2002-12-28 |
| HUP0001386A2 (hu) | 2001-04-28 |
| NO992724L (no) | 1999-06-04 |
| TR199901702T2 (en) | 1999-09-21 |
| IL129936A0 (en) | 2000-02-29 |
| ZA9710919B (en) | 1999-06-04 |
| KR20000069308A (ko) | 2000-11-25 |
| ID23373A (id) | 2000-04-20 |
| CN1239887A (zh) | 1999-12-29 |
| NZ335750A (en) | 2001-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR009651A1 (es) | Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas | |
| FR2405711A1 (fr) | Composition pharmaceutique contenant de l'amoxycilline et du clavulanate de potassium | |
| ES2194732T3 (es) | Composiciones farmaceuticas orales de liberacion controlada de mesalazina. | |
| DE69940769D1 (de) | Orale flüssige zusammensetzungen | |
| ES2154650T3 (es) | Composicion que comprende una formulacion con factor de coagulacion viii, procedimiento para su preparacion y uso de un tensioactivo como estabilizador. | |
| BRPI0009249A (pt) | formulação farmacêutica parenteral de equinocandina contendo tensoativos de formação de micela. | |
| ES2184310T3 (es) | Formulacion autoemulsionante para compuestos lipofilos acidos. | |
| ES2187467T3 (es) | Composiciones liquidas de proteccion solar con buena deposicion y formacion de espuma. | |
| ES2110377T1 (es) | Formulacion galenica de fenofibrato y aplicacion de la misma. | |
| ATE269708T1 (de) | Formulierung enthaltend testosteonundecanoat und rizinusöl | |
| AR030064A1 (es) | Metodos para inhibir los efectos uterotroficos de los agentes estrogenicos | |
| CA2175494A1 (en) | Microparticular Pharmaceutical Compositions | |
| SE0102843D0 (sv) | Stabilized oral pharmaceutical composition containing lodide and lodate and method | |
| ES2224917T1 (es) | Composiciones farmaceuticas de agente fibrinolitico. | |
| GB2391471B (en) | Pharmaceutical compositions | |
| BRPI0611170A2 (pt) | composições injetáveis e processo para o preparo de tais composições | |
| JP4509552B2 (ja) | 向上されたバイオアベイラビリティを有する経口医薬組成物 | |
| PE3096A1 (es) | Formulacion conteniendo selenio | |
| CA1249223A (en) | Solid drug formulations and stable suspensions | |
| PE20030545A1 (es) | Formulaciones de jarabe de ribavirina | |
| RU99114019A (ru) | Фармацевтические композиции, содержащие производные n-сульфонилиндолина | |
| PE20010568A1 (es) | Formulaciones orales de liberacion controlada | |
| PE20030350A1 (es) | Solvatos de clorhidrato de lercanipidina y novedosas formas cristalinas de clorhidrato de lercanidipina que se obtienen a partir de dichos solvatos | |
| UY26177A1 (es) | Polimorfos de un citrato de azobiciclo (2.2.2) oct-3- ilamina cristalino y sus composiciones farmacéuticas. | |
| BRPI0416341A (pt) | composição farmacêutica destinada à administração oral de um derivado de pirazol-3-carboxamida |